Tubulointerstitial fibrosis
|
phenotype |
|
Disease or Syndrome
|
328
|
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Caffeine related disorders
|
group |
|
Mental or Behavioral Dysfunction
|
360
|
56
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
alcohol effect
|
phenotype |
|
Disease or Syndrome
|
13
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Atrophy of the spinal cord
|
disease |
|
Disease or Syndrome
|
13
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
|
disease |
|
Finding
|
149
|
527
|
0.100 |
None |
1.000 |
1 |
4
|
2010 |
2010 |
HIV-1, RESISTANCE TO
|
phenotype |
|
Finding
|
147
|
526
|
0.100 |
None |
1.000 |
1 |
4
|
2010 |
2010 |
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
|
phenotype |
|
Finding
|
147
|
526
|
0.100 |
None |
1.000 |
1 |
4
|
2010 |
2010 |
AIDS, PROGRESSION TO
|
phenotype |
|
Finding
|
147
|
526
|
0.100 |
None |
1.000 |
1 |
4
|
2010 |
2010 |
Vasculitic neuropathy
|
disease |
|
Disease or Syndrome
|
13
|
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Limb ischemia
|
disease |
|
Disease or Syndrome
|
171
|
3
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
FCD IIB
|
disease |
|
Disease or Syndrome
|
15
|
2
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Behavioral Symptoms
|
group |
Behavior and Behavior Mechanisms
|
Sign or Symptom
|
45
|
9
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Abnormal behavior
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
910
|
121
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Arteriosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
2006
|
267
|
0.050 |
None |
1.000 |
5 |
|
2005 |
2019 |
Atherosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
2044
|
281
|
0.040 |
None |
1.000 |
4 |
|
2005 |
2019 |
Vascular Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
688
|
40
|
0.030 |
None |
0.667 |
3 |
|
2006 |
2019 |
Cardiac Arrest
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
411
|
50
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Arteriolosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
13
|
2
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Vascular inflammations
|
phenotype |
Cardiovascular Diseases
|
Disease or Syndrome
|
305
|
3
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Marijuana Abuse
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
156
|
23
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
AURAL ATRESIA, CONGENITAL
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Disease or Syndrome
|
110
|
29
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Adenomatous Polyposis Coli
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
609
|
237
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Cystic Fibrosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases; Respiratory Tract Diseases
|
Disease or Syndrome
|
852
|
704
|
0.020 |
None |
1.000 |
2 |
|
2007 |
2009 |
Cone-Rod Dystrophy 2
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases
|
Disease or Syndrome
|
254
|
51
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Behcet Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases; Skin and Connective Tissue Diseases; Stomatognathic Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
502
|
243
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |